Mentice AB (OSTO:MNTC) Total Long-Term Assets: kr129.8 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:MNTC Mentice AB OSTO:MNTC
79 GF Score
Price kr14.95
GF Value kr22.42
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Mentice AB Total Long-Term Assets?

Mentice AB OSTO:MNTC +0.67% 79 Total Long-Term Assets is kr129.8 Mil as of Jun. 2026. GuruFocus rates OSTO:MNTC with a GF Score™ of 79/100 and a GF Value™ of kr22.42 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Mentice AB's Total Long-Term Assets for the quarter that ended in Jun. 2026 was kr129.8 Mil.

Mentice AB Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Mentice AB's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mentice AB Total Long-Term Assets Chart

Mentice AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Long-Term Assets
Get a 7-Day Free Trial Premium Member Only 148.12 168.14 145.46 138.89 136.08

Mentice AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 146.28 139.33 136.08 133.53 129.84
OSTO:MNTC
79GF Score
Mentice AB OSTO:MNTC
Total Long-Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mentice AB Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of kr129.8 Mil mean?
Mentice AB (OSTO:MNTC) has a Total Long-Term Assets of kr129.8 Mil as of Jun. 2026. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Mentice AB and its competitors.
Is Mentice AB's Total Long-Term Assets too high?
Mentice AB's current Total Long-Term Assets is kr129.8 Mil. Overall, Mentice AB has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mentice AB's Total Long-Term Assets compare to ABT and SYK?
Mentice AB's Total Long-Term Assets of kr129.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Medical Devices & Instruments company?
A good Total Long-Term Assets depends on the Medical Devices & Instruments industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Mentice AB and its competitors. Mentice AB's current Total Long-Term Assets is kr129.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mentice AB stock overvalued right now?
Based on GuruFocus' analysis, Mentice AB (OSTO:MNTC) is currently considered Significantly Undervalued. The stock's GF Value™ is kr22.42, compared to a current price of kr14.95 — trading 33.3% below its estimated fair value. The current Total Long-Term Assets is kr129.8 Mil. Mentice AB's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Mentice AB (OSTO:MNTC), the current Total Long-Term Assets is kr129.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mentice AB (OSTO:MNTC) Overvalued in 2026?

Based on GuruFocus' analysis, Mentice AB stock appears to be undervalued. The current stock price of kr14.95 is trading 33.3% below its estimated GF Value™ of kr22.42. GuruFocus considers Mentice AB to be Significantly Undervalued.

Key valuation signals for OSTO:MNTC:

  • Total Long-Term Assets: kr129.8 Mil
  • GF Value™: kr22.42 vs. price of kr14.95 (33.3% below fair value)
  • GF Score™: 79/100 with 4 warning signs

No single metric tells the full story. See the OSTO:MNTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mentice AB Business Description

Other Exchanges MN2:Germany
Address Odinsgatan 10, Gothenburg, SWE, 411 03
Mentice AB is a provider of software and hardware simulation solutions for image guided interventional therapies, offering proficiency based simulation solutions that help healthcare professionals acquire, retain, and enhance procedural skills, improving productivity and outcomes. Its solutions are scientifically validated and developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are covered. Mentice operates in two segments: Medical Device Industry (MDI), providing end-to-end solutions supporting development and launch of interventional therapies, and Healthcare Systems (HCS). Product areas include Mentice VIST, Physical Sim, Mentice Live, and Ankyras. It operates in EMEA, APAC, and the Americas.
79GF Score

Get the complete analysis for OSTO:MNTC

Total Long-Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr14.95
Price
kr22.42
GF Value